These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2093529

  • 1. Analysis of the factors in the cases resistant to recombinant human erythropoietin treatment.
    Suzuki M.
    Contrib Nephrol; 1990; 82():65-71. PubMed ID: 2093529
    [No Abstract] [Full Text] [Related]

  • 2. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H, Nakahashi H, Sawanishi K, Kuze M, Ono T.
    Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
    [Abstract] [Full Text] [Related]

  • 3. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
    Marsden JT, Sherwood RA, Hillis A, Peters TJ.
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Erythropoietin use in peritoneal dialysis patients.
    Zimmerman SW, Johnson CA.
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
    [Abstract] [Full Text] [Related]

  • 6. Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.
    Nakatsuka K, Hino M, Miki T, Nishizawa Y, Tabata T, Inoue T, Morii H.
    Diabetes Care; 1990 Nov; 13(11):1130-1. PubMed ID: 2261828
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reticulocyte count used to assess recombinant human erythropoietin sensitivity in hemodialysis patients.
    Tatsumi N, Kojima K, Tsuda I, Yamagami S, Itoh Y, Tanaka H.
    Contrib Nephrol; 1990 Nov; 82():41-8. PubMed ID: 2093525
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recombinant erythropoietin for the anemia of chronic renal failure.
    Ahmad R, Hand M.
    N Engl J Med; 1987 Jul 16; 317(3):169-70. PubMed ID: 3600706
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The after effect of r-HuEPO in treating anemic hemodialysis patients].
    Chu JQ.
    Zhonghua Hu Li Za Zhi; 1994 Feb 05; 29(2):78-9. PubMed ID: 7788758
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
    Schaefer RM, Heidland A.
    Dtsch Med Wochenschr; 1989 Jun 30; 114(26):1046-9. PubMed ID: 2661190
    [No Abstract] [Full Text] [Related]

  • 19. Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study.
    Pollok M, Bommer J, Gurland HJ, Koch KM, Schoeppe W, Scigalla P, Baldamus CA.
    Contrib Nephrol; 1989 Jun 30; 76():201-11; discussion 212-8. PubMed ID: 2684523
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of recombinant human erythropoietin on hemodynamics in chronic hemodialysis patients].
    Tomura S.
    Nihon Rinsho; 1991 Dec 30; 49 Suppl():695-701. PubMed ID: 1808338
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.